24-May-2023 | D | In terms of Regulation 30 read with Part A Schedule III of SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015, we wish to inform you that the Board of Directors of the Company at its meeting held on May 24, 2023 has transacted the following business: 1) Approved audited standalone results for the quarter and period ended March 31st, 2023; 2) Recommended the payment of 0.50 per equity share as Final Dividend for the financial year 2022-23 subject to approval of shareholders in the Annual General Meeting.
The record date for the purpose of final dividend shall be 18.09.2023
(As per BSE Announcement Dated on 01/09/2023) | 18-Sep-2023 | |
25-May-2022 | D | Final dividend of Rs0.50 per share recommended by the board subject to approval by the Shareholders in the Annual General Meeting | 08-Sep-2022 | |
02-Jul-2021 | D | Outcome of the Board Meeting held on 30.06.2021
Equity Rs.0.5000 per share(5%)Final Dividend
| 08-Sep-2021 | |
29-May-2018 | D | Board approves dividend on 29/05/2018 | 14-Sep-2018 | |
27-May-2017 | D | Lotus Eye Care Hospital Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 27, 2017, inter alia, has recommended a final dividend of Re. 0.50 (i.e. @ 5%) per equity share of Rs. 10/- each fully paid up of the Company for the financial year 2016-17 subject to the approval of the shareholders at the ensuing Annual General Meeting of the Company. The final dividend would be paid within 30 days from the date of its declaration at the AGM. | 02-Aug-2017 | |
24-Jan-2024 | BC | LOTUS EYE HOSPITAL AND INSTITUTE LIMITED has informed BSE about Board Meeting to be held on 14 Feb 2024 to consider financial statements for the period ended December 2024. Financial results.
Appr | 14-Feb-2024 | |
22-Dec-2023 | BC | Source: BSE Announcement PDF
The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on April 04, 20 | 22-Dec-2023 | |
23-Dec-2023 | BC | S Rajkumar
| 22-Dec-2023 | |
27-Oct-2023 | BC | LOTUS EYE HOSPITAL AND INSTITUTE LIMITED has informed BSE about Board Meeting to be held on 14 Nov 2023 to consider financial statements for the period ended September 2023. Financial results.
App | 14-Nov-2023 | |
01-Sep-2023 | BC | AGM 25/09/2023
Proceedings of Annual General Meeting held on 25th September 2023
(As Per BSE Announcement dated on 25.09.2023)
Voting results of 26th Annual General Meeting
(As per BSE An | 25-Sep-2023 | |
Announcement Date24-May-2023
Ex Dividend Date18-Sep-2023
Dividend(%)5
Announcement Date25-May-2022
Ex Dividend Date08-Sep-2022
Dividend(%)5
Announcement Date02-Jul-2021
Ex Dividend Date08-Sep-2021
Dividend(%)5
Announcement Date29-May-2018
Ex Dividend Date14-Sep-2018
Dividend(%)5
Announcement Date27-May-2017
Ex Dividend Date02-Aug-2017
Dividend(%)5
No Bonus has been declared by LOTUSEYE
No Split has been declared by LOTUSEYE
RightsNo Rights has been declared by LOTUSEYE
Book Closure
14-Feb-2024 | - | LOTUS EYE HOSPITAL AND INSTITUTE LIMITED has informed BSE about Board Meeting to be held on 14 Feb 2024 to consider financial statements for the period ended December 2024. Financial results.
Appr |
22-Dec-2023 | 01 Jan'1900 | Source: BSE Announcement PDF
The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on April 04, 20 |
22-Dec-2023 | - | S Rajkumar
|
14-Nov-2023 | - | LOTUS EYE HOSPITAL AND INSTITUTE LIMITED has informed BSE about Board Meeting to be held on 14 Nov 2023 to consider financial statements for the period ended September 2023. Financial results.
App |
25-Sep-2023 | - | AGM 25/09/2023
Proceedings of Annual General Meeting held on 25th September 2023
(As Per BSE Announcement dated on 25.09.2023)
Voting results of 26th Annual General Meeting
(As per BSE An |